- Home
- ERAS vs RSKD Comparison
ERAS vs RSKD Comparison
Compare ERAS & RSKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- RSKD
- Stock Information
- Founded
- ERAS 2018
- RSKD 2012
- Country
- ERAS United States
- RSKD Israel
- Employees
- ERAS N/A
- RSKD N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- RSKD EDP Services
- Sector
- ERAS Health Care
- RSKD Technology
- Exchange
- ERAS Nasdaq
- RSKD Nasdaq
- Market Cap
- ERAS 723.8M
- RSKD 772.5M
- IPO Year
- ERAS 2021
- RSKD 2021
- Fundamental
- Price
- ERAS $2.47
- RSKD $4.82
- Analyst Decision
- ERAS Strong Buy
- RSKD Hold
- Analyst Count
- ERAS 5
- RSKD 9
- Target Price
- ERAS $5.90
- RSKD $5.97
- AVG Volume (30 Days)
- ERAS 1.2M
- RSKD 577.3K
- Earning Date
- ERAS 11-12-2024
- RSKD 11-13-2024
- Dividend Yield
- ERAS N/A
- RSKD N/A
- EPS Growth
- ERAS N/A
- RSKD N/A
- EPS
- ERAS N/A
- RSKD N/A
- Revenue
- ERAS N/A
- RSKD $318,052,000.00
- Revenue This Year
- ERAS N/A
- RSKD $11.11
- Revenue Next Year
- ERAS N/A
- RSKD $4.62
- P/E Ratio
- ERAS N/A
- RSKD N/A
- Revenue Growth
- ERAS N/A
- RSKD 8.61
- 52 Week Low
- ERAS $1.64
- RSKD $4.14
- 52 Week High
- ERAS $3.45
- RSKD $6.65
- Technical
- Relative Strength Index (RSI)
- ERAS 42.73
- RSKD 53.88
- Support Level
- ERAS $2.51
- RSKD $4.77
- Resistance Level
- ERAS $2.68
- RSKD $5.19
- Average True Range (ATR)
- ERAS 0.21
- RSKD 0.16
- MACD
- ERAS -0.04
- RSKD -0.01
- Stochastic Oscillator
- ERAS 14.56
- RSKD 26.23
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About RSKD Riskified Ltd.
Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.